Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
64 /100
HIGH RISK
Score updated Oct 13, 2026

ENGN — enGene Therapeutics Inc. Dilution Risk Tracker

Track ENGN dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ENGN — Get alerts when the score changes →

As of October 13, 2026, enGene Therapeutics Inc. (ENGN) has a DilutionWatch DilutionScore of 64/100, rated HIGH dilution risk. enGene Therapeutics Inc. has a market capitalization of $113.93M, 67.02M shares outstanding, 10 institutional holders tracked. Stored dilution-related fields include shelf registration capacity of $400.00M, ATM program capacity of $100.00M, 8.55M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
100
💰 Cash Runway
0
📊 Float Risk
75
⚠️ Warrant Exposure
50
🔄 Convertible Debt
85

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 44%
🔁 Convertible Conversion model 60%
• Major convertible overhang: 33% potential dilution
• Convertible risk score very high (85/100)
💰 Capital Raise model 38%
• Active shelf registration ($400M, 351% of market cap)
• Active ATM program with $100M remaining capacity
📜 Warrant Exercise model 15%
• Warrant overhang: 12.8% of shares outstanding
🔔 Track ENGN — Get forecast alerts →

Market Data

Market Cap$113.93M
Shares Outstanding67.02M
Float22.49M
Cash$266.32M
Debt$33.46M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore64/100DilutionWatch score record
Shares Outstanding67.02MVerified float table or market cache
Public Float22.49MVerified float table or market cache
Market Cap$113.93MMarket data cache
Cash Runway46.9 monthsDilutionWatch score inputs
Shelf Capacity$400.00MSEC-derived dilution fields
ATM Capacity$100.00MSEC-derived dilution fields
Outstanding Warrants8.55MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 1, 424B5 1, 8-K 1, EFFECT 1, S-3 1, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

10 institutional holders · 42.50M shares
#1 FCPM III Services B.V. 9.63M shares
#2 Perceptive Advisors Llc 5.87M shares
#3 VR Adviser, LLC 4.77M shares
+ 7 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest1.39M
Days to Cover1.8
% of Float6.2%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-09-08
xbrl XBRL CONVERTIBLE 2024-12-19
8-K 8K EVENT 2026-03-09
424B5 ATM 2026-03-09
EFFECT EFFECT 2026-03-02
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual ENGN Dilution Snapshot

enGene Therapeutics Inc. (ENGN) has a DilutionScore of 64/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

ENGN's DilutionScore is currently 64/100 (High risk), with 3 score changes tracked over 89 days. The score improved from 63/100 (High risk).

Period Score Risk Level Duration
Sep 28 – Oct 13, 202664/100HIGH16 days
Aug 22 – Sep 27, 202663/100HIGH37 days
Aug 14 – Aug 21, 202650/100MEDIUM7 days
Jul 16 – Aug 13, 202663/100HIGH29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

ENGN shares outstanding have decreased 0.0% from 66.99M (May 2026) to 66.99M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 22, 202666.99M22.49M▲ 22.85%
May 18, 202666.99M18.30M▲ 28.33%
May 17, 202666.99M14.26M▼ 35.13%
May 15, 202666.99M21.99M▼ 13.53%
May 09, 202666.99M25.43M▼ 3.82%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track ENGN Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment ENGN files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking ENGN — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations